Literature DB >> 27339196

Preeclampsia and health risks later in life: an immunological link.

Shi-Bin Cheng1, Surendra Sharma2.   

Abstract

Pregnancy represents a period of physiological stress, and although this stress is experienced for a very modest portion of life, it is now recognized as a window to women's future health, often by unmasking predispositions to conditions that only become symptomatic later in life. In normal pregnancy, the mother experiences mild metabolic syndrome-like condition through week 20 of gestation. A pronounced phenotype of metabolic syndrome may program pregnancy complications such as preeclampsia. Preeclampsia is a serious complication with a myriad of manifestations for mother and offspring. This pregnancy syndrome is a polygenic disease and has been now linked to higher incidence of cardiovascular disease, diabetes, and several other disorders associated with vulnerable organs. Furthermore, the offspring born to preeclamptic mothers also exhibit an elevated risk of cardiovascular disease, stroke, and mental disorders during adulthood. This suggests that preeclampsia not only exposes the mother and the fetus to complications during pregnancy but also programs chronic diseases in later life. The etiology of preeclampsia is thought to be primarily associated with poor placentation and entails excessive maternal inflammation and endothelial dysfunction. It is well established now that the maternal immune system and the placenta are involved in a highly choreographed cross-talk that underlies adequate spiral artery remodeling required for uteroplacental perfusion and free flow of nutrients to the fetus. Since normal pregnancy is associated with a sequence of events represented by temporal events of inflammation (implantation), anti-inflammation (gestation), and inflammation (parturition), it is quite possible that unscheduled alterations in these regulatory responses may lead to pathologic consequences. Although it is not clear whether immunological alterations occur early in pregnancy, it is proposed that dysregulated systemic and placental immunity contribute to impaired angiogenesis and the onset of preeclampsia. This review will focus on important aspects of the immune system that coordinate with placental dysfunction to program preeclampsia and influence health in later life.

Entities:  

Keywords:  Aggregated proteins; Chronic diseases; Damage-associated molecular patterns; Immune tolerance; Inflammation; Microparticles; NK cells; Preeclampsia; Regulatory T cells

Mesh:

Substances:

Year:  2016        PMID: 27339196     DOI: 10.1007/s00281-016-0579-8

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  99 in total

Review 1.  Immunology of pre-eclampsia.

Authors:  Christopher W G Redman; Ian L Sargent
Journal:  Am J Reprod Immunol       Date:  2010-03-23       Impact factor: 3.886

2.  Soluble endoglin contributes to the pathogenesis of preeclampsia.

Authors:  Shivalingappa Venkatesha; Mourad Toporsian; Chun Lam; Jun-ichi Hanai; Tadanori Mammoto; Yeon M Kim; Yuval Bdolah; Kee-Hak Lim; Hai-Tao Yuan; Towia A Libermann; Isaac E Stillman; Drucilla Roberts; Patricia A D'Amore; Franklin H Epstein; Frank W Sellke; Roberto Romero; Vikas P Sukhatme; Michelle Letarte; S Ananth Karumanchi
Journal:  Nat Med       Date:  2006-06-04       Impact factor: 53.440

Review 3.  Natural killer cells and regulatory T cells in early pregnancy loss.

Authors:  Surendra Sharma
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

Review 4.  Redefining preeclampsia using placenta-derived biomarkers.

Authors:  Anne Cathrine Staff; Samantha J Benton; Peter von Dadelszen; James M Roberts; Robert N Taylor; Robert W Powers; D Stephen Charnock-Jones; Christopher W G Redman
Journal:  Hypertension       Date:  2013-03-04       Impact factor: 10.190

Review 5.  A leading role for the immune system in the pathophysiology of preeclampsia.

Authors:  Estibalitz Laresgoiti-Servitje
Journal:  J Leukoc Biol       Date:  2013-04-30       Impact factor: 4.962

Review 6.  Review: hCG, preeclampsia and regulatory T cells.

Authors:  W Norris; T Nevers; S Sharma; S Kalkunte
Journal:  Placenta       Date:  2011-02-04       Impact factor: 3.481

7.  Toll-like receptor 9 activation: a novel mechanism linking placenta-derived mitochondrial DNA and vascular dysfunction in pre-eclampsia.

Authors:  Styliani Goulopoulou; Takayuki Matsumoto; Gisele F Bomfim; R Clinton Webb
Journal:  Clin Sci (Lond)       Date:  2012-10       Impact factor: 6.124

Review 8.  Preeclampsia and Vascular Function: A Window to Future Cardiovascular Disease Risk.

Authors:  Davaasambuu Enkhmaa; Danielle Wall; Puja K Mehta; Jennifer J Stuart; Janet Wilson Rich-Edwards; C Noel Bairey Merz; Chrisandra Shufelt
Journal:  J Womens Health (Larchmt)       Date:  2016-01-18       Impact factor: 2.681

9.  Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles.

Authors:  Sarah J Germain; Gavin P Sacks; Suren R Sooranna; Suren R Soorana; Ian L Sargent; Christopher W Redman
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

10.  Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia.

Authors:  Brigitte Santner-Nanan; Michael John Peek; Roma Khanam; Luise Richarts; Erhua Zhu; Barbara Fazekas de St Groth; Ralph Nanan
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

View more
  22 in total

1.  Beyond the "take-home baby": pregnancy as a modulator of organ-specific immunity in mother and offspring.

Authors:  Petra Clara Arck
Journal:  Semin Immunopathol       Date:  2016-10-10       Impact factor: 9.623

2.  Autophagy-Based Diagnosis of Pregnancy Hypertension and Pre-Eclampsia.

Authors:  Surendra Sharma
Journal:  Am J Pathol       Date:  2018-09-19       Impact factor: 4.307

Review 3.  Maternal-fetal cross talk through cell-free fetal DNA, telomere shortening, microchimerism, and inflammation.

Authors:  Shi-Bin Cheng; Sarah Davis; Surendra Sharma
Journal:  Am J Reprod Immunol       Date:  2018-03-25       Impact factor: 3.886

Review 4.  The Impact of Sex and Gender on Stroke.

Authors:  Kathryn M Rexrode; Tracy E Madsen; Amy Y X Yu; Cheryl Carcel; Judith H Lichtman; Eliza C Miller
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 17.367

5.  MiR-133b regulates oxidative stress injury of trophoblasts in preeclampsia by mediating the JAK2/STAT3 signaling pathway.

Authors:  Hai-Yan Yang
Journal:  J Mol Histol       Date:  2021-10-08       Impact factor: 2.611

6.  Women with Adverse Pregnancy Outcomes Have Higher Odds of Midlife Stroke: The Population Assessment of Tobacco and Health Study.

Authors:  Eliza C Miller; Natalie A Bello; Rindcy Davis; Alexander M Friedman; Mitchell S V Elkind; Ronald Wapner; Sarah E Tom
Journal:  J Womens Health (Larchmt)       Date:  2021-11-26       Impact factor: 3.017

7.  Early predictors of Guillain-Barré syndrome in the life course of women.

Authors:  Nathalie Auger; Caroline Quach; Jessica Healy-Profitós; Trish Dinh; Michaël Chassé
Journal:  Int J Epidemiol       Date:  2018-02-01       Impact factor: 7.196

Review 8.  Placental extracellular vesicles and pre-eclampsia.

Authors:  Jessica Schuster; Shi-Bin Cheng; James Padbury; Surendra Sharma
Journal:  Am J Reprod Immunol       Date:  2020-07-18       Impact factor: 3.886

Review 9.  Aggrephagy Deficiency in the Placenta: A New Pathogenesis of Preeclampsia.

Authors:  Akitoshi Nakashima; Tomoko Shima; Sayaka Tsuda; Aiko Aoki; Mihoko Kawaguchi; Atsushi Furuta; Ippei Yasuda; Satoshi Yoneda; Akemi Yamaki-Ushijima; Shi-Bin Cheng; Surendra Sharma; Shigeru Saito
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

10.  Aspirin reduces long-term stroke risk in women with prior hypertensive disorders of pregnancy.

Authors:  Eliza C Miller; Amelia K Boehme; Nadia T Chung; Sophia S Wang; James V Lacey; Kamakshi Lakshminarayan; Charlie Zhong; Daniel Woo; Natalie A Bello; Ronald Wapner; Mitchell S V Elkind; Joshua Z Willey
Journal:  Neurology       Date:  2018-12-26       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.